You are here

pexidartinib

Daiichi Sankyo scores landmark FDA OK for rare tumor drug — albeit with restrictions

Endpoints

Mon, 08/5/19 - 11:32 am

tenosynovial giant cell tumors

Daiichi Sankyo Takes Two Products to FDA Advisory Panel; Gets One Yes, One No

BioSpace

Wed, 05/15/19 - 11:42 am

acute myeloid leukemia

Daiichi gets speedy FDA review for rare cancer drug

Pharmaforum

Fri, 02/8/19 - 09:38 am

priority review